353 related articles for article (PubMed ID: 9023651)
1. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
Croft SL; Snowdon D; Yardley V
J Antimicrob Chemother; 1996 Dec; 38(6):1041-7. PubMed ID: 9023651
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of (2,2':6',2''-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei.
Lowe G; Droz AS; Vilaivan T; Weaver GW; Tweedale L; Pratt JM; Rock P; Yardley V; Croft SL
J Med Chem; 1999 Mar; 42(6):999-1006. PubMed ID: 10090783
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitrypanosomal activities of novel pyridylchalcones.
Bhambra AS; Ruparelia KC; Tan HL; Tasdemir D; Burrell-Saward H; Yardley V; Beresford KJM; Arroo RRJ
Eur J Med Chem; 2017 Mar; 128():213-218. PubMed ID: 28189085
[TBL] [Abstract][Full Text] [Related]
4. Aspects of the cytological activity of edelfosine, miltefosine, and ilmofosine in Leishmania donovani.
Azzouz S; Maache M; Dos Santos MF; Sarciron ME; Petavy AF; Osuna A
J Parasitol; 2006 Oct; 92(5):877-83. PubMed ID: 17152926
[TBL] [Abstract][Full Text] [Related]
5. Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations.
Papagiannaros A; Bories C; Demetzos C; Loiseau PM
Biomed Pharmacother; 2005 Dec; 59(10):545-50. PubMed ID: 16325367
[TBL] [Abstract][Full Text] [Related]
6. Antileishmanial activity of the ether phospholipid ilmofosine.
Croft SL; Neal RA; Thornton EA; Herrmann DB
Trans R Soc Trop Med Hyg; 1993; 87(2):217-9. PubMed ID: 8337733
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
8. Leishmanicidal activity of edelfosine, miltefosine and ilmofosine.
Azzouz S; Maache M; Garcia RG; Osuna A
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):60-5. PubMed ID: 15667597
[TBL] [Abstract][Full Text] [Related]
9. Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents.
Saccoliti F; Madia VN; Tudino V; De Leo A; Pescatori L; Messore A; De Vita D; Scipione L; Brun R; Kaiser M; Mäser P; Calvet CM; Jennings GK; Podust LM; Costi R; Di Santo R
Eur J Med Chem; 2018 Aug; 156():53-60. PubMed ID: 30006174
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.
Jagu E; Pomel S; Diez-Martinez A; Ramiandrasoa F; Krauth-Siegel RL; Pethe S; Blonski C; Labruère R; Loiseau PM
Bioorg Med Chem; 2017 Jan; 25(1):84-90. PubMed ID: 27793448
[TBL] [Abstract][Full Text] [Related]
11. Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis.
Santa-Rita RM; Lira R; Barbosa HS; Urbina JA; de Castro SL
J Antimicrob Chemother; 2005 May; 55(5):780-4. PubMed ID: 15790672
[TBL] [Abstract][Full Text] [Related]
12. Squalamine analogues as potential anti-trypanosomal and anti-leishmanial compounds.
Khabnadideh S; Tan CL; Croft SL; Kendrick H; Yardley V; Gilbert IH
Bioorg Med Chem Lett; 2000 Jun; 10(11):1237-9. PubMed ID: 10866389
[TBL] [Abstract][Full Text] [Related]
13. In vitro antitrypanosomal activity of Moringa stenopetala leaves and roots.
Mekonnen Y; Yardley V; Rock P; Croft S
Phytother Res; 1999 Sep; 13(6):538-9. PubMed ID: 10479771
[TBL] [Abstract][Full Text] [Related]
14.
Nefertiti ASG; Batista MM; Da Silva PB; Batista DGJ; Da Silva CF; Peres RB; Torres-Santos EC; Cunha-Junior EF; Holt E; Boykin DW; Brun R; Wenzler T; Soeiro MNC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203485
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 9,9-dimethylxanthene tricyclics against trypanothione reductase, Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani.
Chibale K; Visser M; Yardley V; Croft SL; Fairlamb AH
Bioorg Med Chem Lett; 2000 Jun; 10(11):1147-50. PubMed ID: 10866368
[TBL] [Abstract][Full Text] [Related]
16. Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi.
Santa-Rita RM; Santos Barbosa H; Meirelles MN; de Castro SL
Acta Trop; 2000 Mar; 75(2):219-28. PubMed ID: 10708662
[TBL] [Abstract][Full Text] [Related]
17. [Rational concepts and the study of active molecules against various trypanosomiases].
Périé J; de Albuquerque C; Blonski C; Chauvière G; Gefflaut T; Page P; Trinquier M; Willson M
Bull Soc Pathol Exot; 1994; 87(5):353-61. PubMed ID: 7496200
[TBL] [Abstract][Full Text] [Related]
18. New leads for trypanosomiasis chemotherapy.
Lancet; 1978 Dec; 2(8101):1190. PubMed ID: 82152
[No Abstract] [Full Text] [Related]
19. Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites.
Baliani A; Bueno GJ; Stewart ML; Yardley V; Brun R; Barrett MP; Gilbert IH
J Med Chem; 2005 Aug; 48(17):5570-9. PubMed ID: 16107157
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M; Chatelain E; Ioset JR
Bioorg Med Chem; 2015 Oct; 23(19):6467-76. PubMed ID: 26344593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
